naproxen-e mylan (naproxen-e mylan) magasýruþolin tafla 250 mg
viatris limited - naproxenum inn - magasýruþolin tafla - 250 mg
naproxen-e mylan (naproxen-e mylan) magasýruþolin tafla 500 mg
viatris limited - naproxenum inn - magasýruþolin tafla - 500 mg
panodil extra filmuhúðuð tafla 500/65 mg
haleon denmark aps - paracetamolum inn; coffeinum - filmuhúðuð tafla - 500/65 mg
parapró filmuhúðuð tafla 200/500 mg
acare ehf. - paracetamolum inn; ibuprofenum inn - filmuhúðuð tafla - 200/500 mg
pinex endaþarmsstíll 500 mg
teva b.v.* - paracetamolum inn - endaþarmsstíll - 500 mg
pinex junior endaþarmsstíll 125 mg
teva b.v.* - paracetamolum inn - endaþarmsstíll - 125 mg
pinex junior endaþarmsstíll 250 mg
teva b.v.* - paracetamolum inn - endaþarmsstíll - 250 mg
ursochol (ursodiol) hart hylki 250 mg
orifarm generics a/s - acidum ursodeoxycholicum inn - hart hylki - 250 mg
ibuprofen zentiva filmuhúðuð tafla 600 mg
zentiva k.s.* - ibuprofenum inn - filmuhúðuð tafla - 600 mg
qaialdo
nova laboratories ireland limited - spironolactone - edema; heart failure; liver cirrhosis; ascites; nephrotic syndrome; hyperaldosteronism; essential hypertension - antihypertensives and diuretics in combination - in the management of refractory oedema associated with congestive cardiac failure; hepatic cirrhosis with ascites and oedema, malignant ascites, nephrotic syndrome, diagnosis and treatment of primary aldosteronism, essential hypertension. neonates, children and adolescents should only be treated under guidance of a paediatric specialist (see sections 5. 1 5.